Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2004
10/28/2004US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders
10/28/2004US20040214209 Receptor protein for use as tool in kit for detection of immunoglobulins
10/28/2004US20040214203 Genes related to sensitivity and resistance to chemotherapeutic drug treatment
10/28/2004US20040214190 Mammalian c-type lectins
10/28/2004US20040214172 Sheeplice, bovicola ovis, allergen treatment
10/28/2004US20040214171 Cat kidney disease marker
10/28/2004US20040214160 Using viruses to detect or purify proteins
10/28/2004US20040214158 Treatment of human papillomavirus (hpv)-infected cells
10/28/2004US20040213802 Gene of novel corynebacterium diphtheriae antigen
10/28/2004US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
10/28/2004US20040213797 Conjugates for the modulation of immune responses
10/28/2004US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis
10/28/2004US20040213790 VEGF-related protein
10/28/2004US20040213777 Methods of applying a biological composition to an individual
10/28/2004US20040213769 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
10/28/2004US20040213768 a cell population capable of producing one or more factors, or a cell culture capable of producing one or more factors or conditioned media from a cell culture containing one or more factors
10/28/2004US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3
10/28/2004US20040213753 administrating to a skin or hair of a candidate a sponge protein hydrolysate which is a product by acidic hydrolysis of sponge skeleton fibers (spongin fibers) obtained from refined sponges as the raw material in an amount effective to stimulate cell growth of the skin or hair
10/28/2004DE10317578A1 Using material based on chitosan and an acid in orthopedics, particularly as replacement for periosteum, also as matrix for growing or encapsulating cells
10/28/2004CA2548643A1 System capable of treating and defining various diseases using stem cells
10/28/2004CA2522543A1 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
10/28/2004CA2522050A1 Method of growing sperm stem cells in vitro, sperm stem cells grown by the method, and medium additive kit to be used in growing sperm stem cells in vitro
10/28/2004CA2521979A1 Compositions and methods related to production of erythropoietin
10/28/2004CA2521754A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
10/27/2004EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein
10/27/2004EP1471146A2 A packaging cell line expressing for use in facilitating the development of high capacity adenoviral vectors
10/27/2004EP1471145A2 Pesticipal proteins and strains
10/27/2004EP1471144A1 Biological variability of asthma associated factor, AAF2 (IL-9 receptor), useful in treating and diagnosing atopic allergies including asthma and related disorders
10/27/2004EP1471140A1 Liquid for frozen storage of primate embryo stem cells and frozen storage method
10/27/2004EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents
10/27/2004EP1470821A2 Cell therapy method for the treatment of tumours
10/27/2004EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
10/27/2004EP1470240A2 Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747,1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165,2
10/27/2004EP1470239A2 Psoriasin expression by breast epithelial cells
10/27/2004EP1470237A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
10/27/2004EP1470236A2 Methods and compositions for protein expression and purification
10/27/2004EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells
10/27/2004EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
10/27/2004EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes
10/27/2004EP1470217A1 Generation and use of dendritic cells
10/27/2004EP1470216A2 Hair follicle growth
10/27/2004EP1470159A2 Antibody to latent membrane proteins and uses thereof
10/27/2004EP1470158A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
10/27/2004EP1470155A2 Pluripotency determining factors and uses thereof
10/27/2004EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
10/27/2004EP1470145A2 Methods and materials for modulating p2x2
10/27/2004EP1469888A2 Stem cell screening and transplantation therapy for hiv infection
10/27/2004EP1469883A2 Compositions and methods for regulating lymphocyte activation
10/27/2004EP1469878A2 Fgfr agonists
10/27/2004EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
10/27/2004EP1469870A2 Novel compositions and methods for cancer
10/27/2004EP1469852A2 Nitric oxide donors for treatment of disease and injury
10/27/2004EP1469810A2 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders
10/27/2004EP1469769A2 Novel compositions and methods for cancer
10/27/2004EP1469730A2 Methods and compositions for treating parkinson's disease
10/27/2004EP1276894B1 Method for screening of microorganisms under nutrient limited conditions
10/27/2004EP1276851B1 Tolerance-inducing thymus-bone marrow composite tissue construct and organ
10/27/2004EP1237578A4 Micro-cluster liquids and methods of making and using them
10/27/2004EP1141022B1 Serine protease inhibitor
10/27/2004EP1027027A4 Therapeutic method
10/27/2004EP1002116B1 Method of producing a drought-tolerant plant
10/27/2004EP1002067A4 Strong early seed-specific gene regulatory region
10/27/2004EP0956340B1 In culture proliferation of human pancreatic endocrine cells
10/27/2004EP0871885B1 Attachment enhanced 293 cells
10/27/2004EP0831877B1 Metabolic effects of certain glutathione analogs
10/27/2004EP0763107B1 Pantropic neurotrophic factors
10/27/2004EP0759992B1 Human papilloma virus inhibition by a hairpin ribozyme
10/27/2004EP0721015B1 Monoclonal antibody that induces apoptosis
10/27/2004EP0717108B1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
10/27/2004CN2651257Y Mechanical agitating reactor
10/27/2004CN1541334A Cardiovascular safety assay
10/27/2004CN1541323A Cryopreservation system with controlled dendritic freezing front velocity
10/27/2004CN1541273A Monocdyledon plant cells and plants which synthesise modified starch
10/27/2004CN1541270A Herbicide resistant plants
10/27/2004CN1541266A FCE fusion proteins for treatment of allergy and asthma
10/27/2004CN1541265A Identification of DNA variant associated with adult type hypolactasia
10/27/2004CN1541264A Lipoxygenase
10/27/2004CN1541226A Antibodes specific for CD44V6
10/27/2004CN1541225A Humanized antibodies that recognize beta amyloid peptide
10/27/2004CN1541223A Expression of functional human olfactory cyclic nucleotide gated (CNG)channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
10/27/2004CN1541113A Maturation of antigen-presenting cells using activated T cells
10/27/2004CN1541111A Mutant forms of cholera holotoxin as adjuvant
10/27/2004CN1541109A Inhibitors of HER3 activity
10/27/2004CN1541107A Growth factor complex
10/27/2004CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation
10/27/2004CN1539972A cDNA segment of controlling growth of microspore of paddy, coded result and application
10/27/2004CN1539970A Heterophil neutral leucocyte factor alpha
10/27/2004CN1539964A Method for amplifying hemopoietic stem cell/hemopoietic progenitor cell supprted by mesonchyme stem cell in bleeding of umbilicus
10/27/2004CN1539963A Method for cltivating cartilage cells in knee joint of BALB/c chmice
10/27/2004CN1539962A Method for separating silk gland cell of silkworm suited to researches in molecular biology
10/27/2004CN1539961A Method for separatng cell of extracorporeal gastic mucosa and relevant purification method
10/27/2004CN1539960A Black culture medium and preparation method
10/27/2004CN1539849A Polypeptides encoded by haman lipase-like gene and compsns, and metods of utilizing same
10/27/2004CN1173039C Variant loxP sequences and application of the same
10/27/2004CN1173037C Single-chain bifunctional glycoprotein hormones
10/27/2004CN1173034C TSA 305 gene
10/27/2004CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
10/27/2004CN1173031C Macroporous chitosan beads and preparation method thereof
10/27/2004CN1172718C Dendritic cell stimulatory factor
10/26/2004US6809239 Choline monooxygenase gene